Ruben A. Mesa

机构：Atrium Health Wake Forest Baptist, The University of Texas MD Anderson Cancer Center, The University of Texas at San Antonio Health Science Center, Levine Cancer Institute, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University · ORCID：0000-0001-5880-7972

发表论文 1293 篇 · 总被引 47010 次 · h-index 99

代表论文

• Personalized Hemodynamic Resuscitation Targeting Capillary Refill Time in Early Septic Shock (2025 · JAMA · 被引 94)
• Ropeginterferon alfa-2b in hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia (SURPASS ET): a multicentre, open-label, randomised, active-controlled, phase 3 study (2025 · The Lancet Haematology · 被引 16)
• Safety and efficacy of INCA033989, a novel first in class mutant calreticulin-specific monoclonal antibody, in patients with essential thrombocythemia (2025 · Blood · 被引 10)
• JAK inhibitor selection in challenging scenarios of myelofibrosis: a review (2025 · Haematologica · 被引 8)
• Durable efficacy and long-term safety with pelabresib plus ruxolitinib in JAK Inhibitor–Naive myelofibrosis: 96-week Results from the Phase III MANIFEST-2 study (2025 · Blood · 被引 6)
• Evaluation of the novel TMPRSS6 antisense inhibitor sapablursen for treatment of polycythemia vera: Results of the imprssion clinical trial (2025 · Blood · 被引 4)